A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals

Launched by MILLION MARKER WELLNESS, INC. · Jun 4, 2024

Keywords

ClinConnect Summary

This clinical trial aims to find out if a tailored program can help people reduce their exposure to harmful chemicals called endocrine disrupting chemicals (EDCs). These chemicals can affect health, especially in individuals of child-bearing age. The study will provide participants with tests to measure EDC levels in their urine, along with feedback on their results. Participants will also have access to an interactive online learning program, live coaching, and a supportive online community. The researchers believe that this comprehensive approach will be more effective than just testing alone in helping people understand environmental health, change their behaviors, and improve their overall well-being.

To join the trial, participants must be between the ages of 18 and 45, not pregnant, and free from certain health conditions like diabetes, kidney disease, or cancer. They should be comfortable reading and understanding English and be willing to complete all study activities. If you participate, you can expect to learn more about how to reduce your exposure to these chemicals and how it may benefit your health and well-being. This trial is currently looking for participants, and everyone is welcome to apply!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • not pregnant, free from diabetes or known kidney disease or cancer (these conditions may interfere with EDC metabolism); able to understand written and spoken English; and willing to complete all study assessments.
• Exclusion Criteria:
• • -